drugset / Trial / NCT01832935
Cost Effectiveness of Glargine Insulin Versus NPH Insulin
RandomizedParallel-groupDouble-blindBasic science
Summary
Glycemic control is fundamental in the management of diabetes mellitus .If lifestyle intervention and full tolerated doses of one or two oral glucose lowering drugs (OGLDs) fail to achieve or sustain glycemic goals, insulin should be initiated. New insulin analogs are generated to improve glycemic control .New insulin analogs are generated to improve glycemic control,However, the cost of these analogs is a major problem .The aim of this piggy back evaluation was to assess the effect of Glargine insuline versus NPH plus regular human insulin on metabolic control as well as its cost-effectiveness in people with type 2 diabetes in the Iranian setting.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | insulin NPH | Protein / enzyme biologic | 24 iu | — |
| Comparator | insulin glargine | Protein / enzyme biologic | 24 iu | — |